This once again support our findings that GSK3α-mediated cell survival and proliferation promotes tumor growth in both early and advanced stages, and that GSK3β/β-catenin-mediated EMT promotes cell motility, invasion and micrometastasis in the advanced stages. This evidence concerns the gene GSK3A and neoplasm.